Selank
A synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, studied for anxiolytic effects without the sedation associated with benzodiazepines.
Any compounds discussed may be intended for research purposes only. Nothing here is a protocol to follow — amounts, timing and cycle lengths are reported as the named speaker described them.
We are not doctors. Use at your own risk.
Overview
Selank is a synthetic peptide based on tuftsin, developed in Russia and used clinically there for anxiety. Research has examined effects on anxiety and on the balance of neurotransmitter and immune signalling, with interest centring on whether an anxiolytic effect can be achieved without sedation or dependence.
As with the other compounds from this research tradition, the literature is largely Russian-language and has not been substantially replicated by independent groups. It is registered as a medicine in Russia and is not approved elsewhere.
What the research examines
Anxiety, stress response, and effects on BDNF and neurotransmitter signalling, from a literature concentrated in one research tradition.
Reported protocols
Attributed to the person who described them. Amounts, timing and interactions as stated on air.
Nobody has described a protocol for Selank on the show. When someone does, it will appear here attributed to them.
Adverse effects
The originating literature reports it as well tolerated without the sedation or dependence associated with benzodiazepines. That record has not been independently verified.
Presentation and storage
Supplied as a nasal solution in its registered form, and as a lyophilised powder elsewhere.
Discussed in
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
New episode alerts, every week
The episode, its chapters and every source cited, straight to your inbox. No fluff. No spam.